Aclarion Terminates Sales Agreement with Ascendiant Capital Markets, LLC

Aclarion, Inc. (NASDAQ: ACON) has announced the termination of the At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC. The termination notice was given on January 3, 2025, and is effective immediately. Under the Sales Agreement entered into on September 24, 2024, Aclarion had the authority to sell shares of its common stock, with a […]

Leave a Reply

Your email address will not be published.

Previous post Johnson Sworn In as Speaker
Next post West Pharmaceutical Services (NYSE:WST) Stock Passes Above 200-Day Moving Average – Here’s Why